Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
84.74B | 84.19B | 81.76B | 94.44B | 81.75B | 66.81B | Gross Profit |
13.34B | 13.15B | 13.10B | 16.55B | 15.44B | 11.77B | EBIT |
5.90B | 5.89B | 6.34B | 8.44B | 7.62B | 4.85B | EBITDA |
10.90B | 10.81B | 10.81B | 12.73B | 11.69B | 8.54B | Net Income Common Stockholders |
3.38B | 3.33B | 3.68B | 5.36B | 5.05B | 2.98B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.25B | 2.19B | 4.26B | 3.19B | 4.71B | 5.80B | Total Assets |
71.63B | 69.88B | 66.83B | 68.28B | 63.59B | 55.31B | Total Debt |
26.55B | 22.44B | 20.83B | 20.22B | 19.02B | 18.35B | Net Debt |
20.26B | 20.30B | 17.18B | 18.39B | 17.39B | 13.87B | Total Liabilities |
47.44B | 45.66B | 43.94B | 44.58B | 44.09B | 41.23B | Stockholders Equity |
23.75B | 23.79B | 22.48B | 23.24B | 19.04B | 13.78B |
Cash Flow | Free Cash Flow | ||||
4.18B | 5.79B | 5.88B | 7.05B | 6.26B | 4.78B | Operating Cash Flow |
8.40B | 8.72B | 9.26B | 10.96B | 9.99B | 7.70B | Investing Cash Flow |
-2.58B | -2.39B | -2.18B | -3.18B | -4.82B | -3.64B | Financing Cash Flow |
-4.06B | -6.35B | -6.90B | -7.41B | -6.22B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €157.56B | 13.96 | 19.60% | 2.84% | 4.90% | 176.57% | |
76 Outperform | €44.98B | 13.44 | 14.23% | 4.72% | 4.50% | -1.85% | |
67 Neutral | €5.31B | 11.79 | 9.85% | ― | 10.66% | 14.62% | |
64 Neutral | $4.39B | 12.06 | 5.17% | 249.63% | 4.03% | -11.04% | |
61 Neutral | $14.93B | 11.58 | 10.07% | 3.14% | -14.83% | 78.73% | |
59 Neutral | €39.74B | 53.78 | 2.02% | 7.62% | -2.04% | 2258.97% | |
56 Neutral | €21.78B | ― | -9.56% | 0.48% | -0.92% | -4.30% |